Course Description

Interferon Gamma Release Assays (IGRAs) have been recommended for use in the diagnosis of Latent TB Infection. Since these recommendations, much has been learned and published regarding the performance of these tests in different clinical situations. This Grand Rounds program will examine “lessons learned” from a “practical” standpoint and share experiences for enhancing the utilization of these tests. Presentation by Dr. Robert Belknap.

Goals:

1. Describe and apply current recommendations for the use of Interferon Gamma Release Assays (IGRAs)
2. Integrate new information concerning the use of IGRAs into varying clinical situations
3. Disseminate programmatic experiences gained from clinical implementation of IGRA with other providers

Objectives:

1. List the benefits and limitations of IGRAs in patients with different TB risks
   • Suspected active TB
   • Special populations
   • High vs. low risk for TB infection​
2.  ​​Describe the operational advantages and disadvantages using IGRA
3. Explain some of the cost issues associated with expanded use of IGRAs

Slides:https://sntc.medicine.ufl.edu//Content/Webinars/SupportingDocs//Webinar%20IGRAs%208-13-13.v2.pdf

Transcript:  https://sntc.medicine.ufl.edu//Content/Webinars/SupportingDocs//Transcript-Webinar%20IGRAs%208-13-13FINAL.pdf